DR info

臨床試験数 : 6 / 薬物数 : 7 - (DrugBank : 4) / 標的遺伝子数 : 16 - 標的パスウェイ数 : 26

薬物ごとの開発者（Primary Sponsor）、臨床試験情報（抜粋）です。

Acetazolamide
   Hospital Son Llatzer
      2011   Phase 3   NCT01499485   Spain;
Cerazette
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2011-000989-35-FR   France;
Desogestrel
   Assistance Publique - Hôpitaux de Paris
      2011   Phase 2/Phase 3   NCT01243697   France;
   Children's Hospital Los Angeles
      2012   -   NCT01500473   United States;
Domperidone
   Karolinska Universitetssjukhuset
      2006   -   EUCTR2005-005950-33-SE   Sweden;
Désogestrel
   ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
      -   Phase 2   EUCTR2011-000989-35-FR   France;
Equal
   Philips Respironics
      2013   -   NCT01964339   United States;
Gold
   First Hospital of Peking university
      2010   -   ChiCTR-DDT-11001215   China;
Ketogenic Diet
   Johns Hopkins University
      2019   -   NCT04108819   United States;
Motilium
   Karolinska Universitetssjukhuset
      2006   -   EUCTR2005-005950-33-SE   Sweden;